Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: update from Japan
- PMID: 24673567
- DOI: 10.1111/iju.12445
Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: update from Japan
Abstract
Peritoneal dialysis is established as a first-line standard renal replacement therapy for end-stage renal disease. However, the development of encapsulating peritoneal sclerosis has been a critical complication among long-term peritoneal dialysis patients. During the past decade, multidisciplinary approaches have been used to suppress encapsulating peritoneal sclerosis. The present article reviews the historical and present status of encapsulating peritoneal sclerosis in Japan.
Keywords: encapsulating peritoneal sclerosis; incremental peritoneal dialysis; neutral solution; peritoneal dialysis; peritoneal dialysis and hemodialysis combination.
© 2014 The Japanese Urological Association.
Comment in
-
Editorial comment to Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: update from Japan.Int J Urol. 2014 Aug;21(8):761-2. doi: 10.1111/iju.12464. Epub 2014 Apr 13. Int J Urol. 2014. PMID: 24724622 No abstract available.
Similar articles
-
2009 Japanese Society for Dialysis Therapy guidelines for peritoneal dialysis.Ther Apher Dial. 2010 Dec;14(6):489-504. doi: 10.1111/j.1744-9987.2010.00901.x. Ther Apher Dial. 2010. PMID: 21118358
-
Encapsulating peritoneal sclerosis--a complication of peritoneal dialysis.N Z Med J. 2011 Sep 9;124(1342):89-93. N Z Med J. 2011. PMID: 21963929
-
Past and present perspectives on encapsulating peritoneal sclerosis.Contrib Nephrol. 2015;185:87-97. doi: 10.1159/000380973. Epub 2015 May 19. Contrib Nephrol. 2015. PMID: 26023018
-
Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis - Position Paper for ISPD: 2017 Update.Perit Dial Int. 2017 Jul-Aug;37(4):362-374. doi: 10.3747/pdi.2017.00018. Perit Dial Int. 2017. PMID: 28676507 Review. No abstract available.
-
Encapsulating Peritoneal Sclerosis.Semin Nephrol. 2017 Jan;37(1):93-102. doi: 10.1016/j.semnephrol.2016.10.010. Semin Nephrol. 2017. PMID: 28153198 Review.
Cited by
-
Recommendations for pathological diagnosis on biopsy samples from peritoneal dialysis patients.Pleura Peritoneum. 2017 Mar 1;2(1):3-15. doi: 10.1515/pp-2016-0028. Epub 2017 Mar 17. Pleura Peritoneum. 2017. PMID: 30911628 Free PMC article. Review.
-
Pathophysiology of encapsulating peritoneal sclerosis: lessons from findings of the past three decades in Japan.Clin Exp Nephrol. 2023 Sep;27(9):717-727. doi: 10.1007/s10157-023-02360-y. Epub 2023 Jun 6. Clin Exp Nephrol. 2023. PMID: 37278945 Free PMC article. Review.
-
Dissolved molecular hydrogen (H2) in Peritoneal Dialysis (PD) solutions preserves mesothelial cells and peritoneal membrane integrity.BMC Nephrol. 2017 Oct 31;18(1):327. doi: 10.1186/s12882-017-0741-0. BMC Nephrol. 2017. PMID: 29089029 Free PMC article.
-
Delayed administration of suramin attenuates peritoneal fibrosis in rats.BMC Nephrol. 2019 Nov 14;20(1):411. doi: 10.1186/s12882-019-1597-2. BMC Nephrol. 2019. PMID: 31727005 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous